2559EGP
- Active ingredient
- fondaparinux sodiom
- Strength
- 7.5mg/0.6ml
- Form
- syringe
- Manufacturer
- glaxo smithkline > phoenix-egypt
- Route
- injection
Uses
Used for prevention and treatment of deep vein thrombosis and pulmonary embolism.
Do not use if
Active major bleeding, severe renal impairment, bacterial endocarditis, or hypersensitivity.
Side effects
Bleeding, anemia, injection-site reactions, and thrombocytopenia may occur.
Warnings
Serious bleeding and spinal or epidural hematomas may occur, especially with neuraxial procedures.
How it works
Selective indirect Factor Xa inhibitor that enhances antithrombin-mediated anticoagulation.
Storage
Store at controlled room temperature according to product labeling.
